Evidence map›Paper›PMID 31027181›Full record

ArticleInternational journal of molecular sciences2019

Role of Dusp6 Phosphatase as a Tumor Suppressor in Non-Small Cell Lung Cancer.

Verónica Moncho-Amor, Laura Pintado-Berninches, Inmaculada Ibañez de Cáceres, Ester Martín-Villar, Miguel Quintanilla, Probir Chakravarty, María Cortes-Sempere, Beatriz Fernández-Varas, Carlos Rodriguez-Antolín, Javier de Castro and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 29 citations in OpenAlex.

  1. Aumolertinib combined with targetingJournal of thoracic disease · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. MicroRNA-211 Modulates the DUSP6-ERK5 Signaling Axis to Promote BRAFThe Journal of investigative dermatology · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Verónica Moncho-AmorDepartment of Experimental Models of Human Diseases, Instituto de Investigaciones Biomédicas C.S.I.C./U.A.M, 28029 Madrid, Spain. Veronica.Moncho-Amor@crick.ac.uk.
Laura Pintado-BerninchesDepartment of Experimental Models of Human Diseases, Instituto de Investigaciones Biomédicas C.S.I.C./U.A.M, 28029 Madrid, Spain. lpintado@iib.uam.es.
Inmaculada Ibañez de CáceresCancer Epigenetics Laboratory, INGEMM, Hospital Universitario La Paz, 28046 Madrid, Spain. inma.ibanezca@gmail.com.ORCID 0000-0001-9805-8486
Ester Martín-VillarDepartamento de Biotecnología-Instituto de Investigaciones Biosanitarias, Facultad de Ciencias Experimentales, Universidad Francisco de Vitoria, 28223 Madrid, Spain. emvillar@iib.uam.es.
Miguel QuintanillaDepartment of Experimental Models of Human Diseases, Instituto de Investigaciones Biomédicas C.S.I.C./U.A.M, 28029 Madrid, Spain. mquintanilla@iib.uam.es.ORCID 0000-0002-2124-7657
Probir ChakravartyBioinformatics, Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK. probir.chakravarty@crick.ac.uk.
María Cortes-SempereDepartment of Experimental Models of Human Diseases, Instituto de Investigaciones Biomédicas C.S.I.C./U.A.M, 28029 Madrid, Spain. airamcortesempere@hotmail.com.
Beatriz Fernández-VarasDepartment of Experimental Models of Human Diseases, Instituto de Investigaciones Biomédicas C.S.I.C./U.A.M, 28029 Madrid, Spain. bfvaras@iib.uam.es.
Carlos Rodriguez-AntolínCancer Epigenetics Laboratory, INGEMM, Hospital Universitario La Paz, 28046 Madrid, Spain. rodriguez.antolin.c@gmail.com.
Javier de CastroBiomarkers and Experimental Therapeutics in Cancer, IdiPAZ, 28046 Madrid, Spain. javier.decastro@salud.madrid.org.
Leandro SastreDepartment of Experimental Models of Human Diseases, Instituto de Investigaciones Biomédicas C.S.I.C./U.A.M, 28029 Madrid, Spain. lsastre@iib.uam.es.ORCID 0000-0003-3613-5938
Rosario PeronaDepartment of Experimental Models of Human Diseases, Instituto de Investigaciones Biomédicas C.S.I.C./U.A.M, 28029 Madrid, Spain. rperona@iib.uam.es.ORCID 0000-0002-2973-5153
Instituto de Investigaciones Biomédicas Sols-Morreale · ESHospital Universitario La Paz · ESThe Francis Crick Institute · GBUniversidad Francisco de Vitoria · ES

Funding

Instituto de Salud Carlos III PI17-01401 and PI18/00050Instituto de Salud Carlos III PI-717 Miguel ServetMinisterio de Ciencia e Innovación SAF2017-84183-R
6 · The paper itself

Abstract

DUSP6/MKP3 is a dual-specific phosphatase that regulates extracellular regulated kinase ERK1/2 and ERK5 activity, with an increasingly recognized role as tumor suppressor. In silico studies from Gene expression Omnibus (GEO) and Cancer Genome atlas (TCGA) databases reveal poor prognosis in those Non-small cell lung cancer (NSCLC) patients with low expression levels of

Indexed as

Genes, Tumor SuppressorActin CytoskeletonAdenocarcinoma of LungAdherens JunctionsAnimalsCarcinogenesisCarcinoma, Non-Small-Cell LungCell AdhesionCell Line, TumorCell MovementCell ShapeDisease ProgressionDual Specificity Phosphatase 6Focal AdhesionsGene Expression Regulation, NeoplasticHumansDual Specificity Phosphatase 6DUSP6 protein, humanTransforming Growth Factor betaDUSP6EMTERK1/2ERK5MKP3tumorigenesistumor suppressor

Identifiers

PMID31027181
PMCPMC6514584
OpenAlexW2941361166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.